Arguments for a different regulatory categorization and framework for stromal vascular fraction

Ricardo L. Rodriguez; Trivia Frazier; Bruce A. Bunnell; Cecilia A. Mouton; Keith L. March; Adam J. Katz; J. Peter Rubin; Ramon Llull; Jens A. Sørensen; Jeffrey M. Gimble

doi:10.1089/scd.2019.0096

Arguments for a different regulatory categorization and framework for stromal vascular fraction

Ricardo L. Rodriguez, Trivia Frazier, Bruce A. Bunnell, Cecilia A. Mouton, Keith L. March, Adam J. Katz, J. Peter Rubin, Ramon Llull, Jens A. Sørensen, Jeffrey M. Gimble

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Although adipose tissue and cells show considerable promise for clinical translation in the emerging field of regenerative medicine, they present a challenge to the regulatory community both nationally and internationally. This commentary evaluates the status of adipose-derived therapeutics and considers regulatory approaches designed to maximize patient safety while advancing clinical translation in accordance with evidence-based medical science.

Original language	English
Pages (from-to)	257-262
Number of pages	6
Journal	Stem Cells and Development
Volume	29
Issue number	5
DOIs	https://doi.org/10.1089/scd.2019.0096
State	Published - 1 Mar 2020

Keywords

adipose-derived stromal/stem cells
cell therapy
regenerative medicine
regulation
stromal vascular fraction cells

Access to Document

10.1089/scd.2019.0096

Cite this

@article{344708d08b1f41d2bd5327cf0f7f185d,

title = "Arguments for a different regulatory categorization and framework for stromal vascular fraction",

abstract = "Although adipose tissue and cells show considerable promise for clinical translation in the emerging field of regenerative medicine, they present a challenge to the regulatory community both nationally and internationally. This commentary evaluates the status of adipose-derived therapeutics and considers regulatory approaches designed to maximize patient safety while advancing clinical translation in accordance with evidence-based medical science.",

keywords = "adipose-derived stromal/stem cells, cell therapy, regenerative medicine, regulation, stromal vascular fraction cells",

author = "Rodriguez, {Ricardo L.} and Trivia Frazier and Bunnell, {Bruce A.} and Mouton, {Cecilia A.} and March, {Keith L.} and Katz, {Adam J.} and Rubin, {J. Peter} and Ramon Llull and S{\o}rensen, {Jens A.} and Gimble, {Jeffrey M.}",

year = "2020",

month = mar,

day = "1",

doi = "10.1089/scd.2019.0096",

language = "English",

volume = "29",

pages = "257--262",

journal = "Stem Cells and Development",

issn = "1547-3287",

publisher = "Mary Ann Liebert Inc.",

number = "5",

}

TY - JOUR

T1 - Arguments for a different regulatory categorization and framework for stromal vascular fraction

AU - Rodriguez, Ricardo L.

AU - Frazier, Trivia

AU - Bunnell, Bruce A.

AU - Mouton, Cecilia A.

AU - March, Keith L.

AU - Katz, Adam J.

AU - Rubin, J. Peter

AU - Llull, Ramon

AU - Sørensen, Jens A.

AU - Gimble, Jeffrey M.

PY - 2020/3/1

Y1 - 2020/3/1

N2 - Although adipose tissue and cells show considerable promise for clinical translation in the emerging field of regenerative medicine, they present a challenge to the regulatory community both nationally and internationally. This commentary evaluates the status of adipose-derived therapeutics and considers regulatory approaches designed to maximize patient safety while advancing clinical translation in accordance with evidence-based medical science.

AB - Although adipose tissue and cells show considerable promise for clinical translation in the emerging field of regenerative medicine, they present a challenge to the regulatory community both nationally and internationally. This commentary evaluates the status of adipose-derived therapeutics and considers regulatory approaches designed to maximize patient safety while advancing clinical translation in accordance with evidence-based medical science.

KW - adipose-derived stromal/stem cells

KW - cell therapy

KW - regenerative medicine

KW - regulation

KW - stromal vascular fraction cells

UR - http://www.scopus.com/inward/record.url?scp=85081141001&partnerID=8YFLogxK

U2 - 10.1089/scd.2019.0096

DO - 10.1089/scd.2019.0096

M3 - Article

C2 - 31797749

AN - SCOPUS:85081141001

SN - 1547-3287

VL - 29

SP - 257

EP - 262

JO - Stem Cells and Development

JF - Stem Cells and Development

IS - 5

ER -

Arguments for a different regulatory categorization and framework for stromal vascular fraction

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this